Docetaxel 20 mg Injection — Taxane Chemotherapy for Solid Tumours Docetaxel 20 mg Injection is a potent taxane-class chemotherapy medicine used in the treatment of various advanced solid cancers including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric (stomach) cancer, and head & neck cancer. Administered via intravenous infusion by trained oncology professionals, docetaxel works by stabilizing microtubules and inhibiting cancer cell division, slowing tumour growth and enhancing treatment outcomes, especially when used in combination regimens. In Pakistan, multiple brands of docetaxel 20 mg are available through licensed oncology pharmacies with a valid prescription. Due to serious side effects like bone marrow suppression, hypersensitivity reactions, and fluid retention, strict clinical monitoring and supportive care (including steroid premedication) are essential. Frequent blood tests and organ function assessments support safe and effective use of docetaxel in cancer therapy.